ABC.L - Abcam plc
| Previous close | 1,206.00 |
| Open | 1,224.00 |
| Bid | 1,165.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 1,197.00 - 1,224.00 |
| 52-week range | 1,006.00 - 1,588.00 |
| Volume | 137,732 |
| Avg. volume | 375,169 |
| Market cap | 2.483B |
| Beta (3Y monthly) | 0.49 |
| PE ratio (TTM) | 43.26 |
| EPS (TTM) | 27.90 |
| Earnings date | 9 Sep 2019 |
| Forward dividend & yield | 0.12 (1.01%) |
| Ex-dividend date | 2019-03-14 |
| 1y target est | 1,334.50 |
- Simply Wall St.
Should Abcam plc (LON:ABC) Focus On Improving This Fundamental Metric?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Fool.co.uk
Why I feel buying the AstraZeneca share price could destroy your retirement riches
Roland Head explains why he's avoiding AstraZeneca plc (LON: AZN).
- Reuters - UK Focus
BUZZ-Abcam: Peel Hunt downgrades to 'add' on valuation
- Simply Wall St.
Is Now The Time To Put Abcam (LON:ABC) On Your Watchlist?
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
- Simply Wall St.
Abcam plc (LON:ABC): Is It A Smart Long Term Opportunity?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Simply Wall St.
Introducing Abcam (LON:ABC), The Stock That Zoomed 215% In The Last Five Years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is Abcam plc (LON:ABC) wh...
- Simply Wall St.
Is Abcam plc (LON:ABC) A Good Dividend Stock?
Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. Historically, Abcam plc (LON:ABC) has paidRead More...
- Business Wire
Abcam Moves to New Purpose-Built Global Headquarters
CAMBRIDGE, England--(BUSINESSWIRE)-- Abcam, a global innovator in life science reagents and tools, is pleased to announce its move to new state-of-the-art global headquarters, Discovery Drive, on the Cambridge ...
- Simply Wall St.
Need To Know: Abcam plc (LON:ABC) Insiders Have Been Selling Shares
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! We've lost count of how many times insiders have accumulatedRead More...
- Simply Wall St.
Why Abcam plc’s (LON:ABC) High P/E Ratio Isn’t Necessarily A Bad Thing
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at Abcam plc's (LON:ABC) P/E ratio and reflect on Read More...
- Business Wire
Abcam Expands Custom Services Capabilities with the Acquisition of Calico Biolabs
CAMBRIDGE, England--(BUSINESSWIRE)-- Abcam, a global innovator in life science reagents and tools, is pleased to announce its acquisition of Calico Biolabs, a developer of custom high-quality recombinant ...
- Simply Wall St.
Will Abcam plc’s (LON:ABC) Earnings Grow Over The Next Few Years?
The most recent earnings update Abcam plc's (LON:ABC) released in June 2018 showed that the business gained from a robust tailwind, leading to a double-digit earnings growth of 47%. Below Read More...
- PR Newswire
A new PD-L1 BOND Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need
NEWCASTLE, England , Nov. 13, 2018 /PRNewswire/ -- Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND ...
- Simply Wall St.
Is Abcam plc’s (LON:ABC) CEO Paid Enough Relative To Peers?
Alan Hirzel has been the CEO of Abcam plc (LON:ABC) since 2014. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar Read More...
- Business Wire
Camallergy Appoints Baxter Phillips III as Chief Executive Officer
Camallergy, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced the appointment of Baxter Phillips III as Chief Executive Officer, effective immediately. Mr. Phillips has also been appointed to the Company’s Board of Directors. Camallergy co-founder Sherden Timmins continues his executive appointment in the newly created role of Chief Operating Officer while company scientific co-founders Dr. Andrew Clark and Dr. Pamela Ewan continue to serve in their current roles as Chief Scientific Officer and Chief Medical Officer.
- Simply Wall St.
What You Must Know About Abcam plc’s (LON:ABC) 18% ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
- Simply Wall St.
How Abcam Plc (LON:ABC) Could Add Value To Your Portfolio
Attractive stocks have exceptional fundamentals. In the case of Abcam Plc (LON:ABC), there’s is a company with great financial health as well as a a strong track record of performance.Read More...
